n-chlorotaurine has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, Y; Park, E; Quinn, MR; Schuller-Levis, G; Tonna-DeMasi, M | 1 |
| Liu, Y; Quinn, MR; Schuller-Levis, G | 1 |
2 other study(ies) available for n-chlorotaurine and Glioma
| Article | Year |
|---|---|
Taurine chloramine inhibits production of nitric oxide and prostaglandin E2 in activated C6 glioma cells by suppressing inducible nitric oxide synthase and cyclooxygenase-2 expression.
Topics: Animals; Blotting, Northern; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Glioma; Humans; Inflammation Mediators; Isoenzymes; Membrane Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Prostaglandin-Endoperoxide Synthases; Rats; RNA, Messenger; Taurine; Tumor Cells, Cultured | 1998 |
Monocyte chemoattractant protein-1 and macrophage inflammatory protein-2 production is inhibited by taurine chloramine in rat C6 glioma cells.
Topics: Animals; Chemokine CCL4; Chemokine CXCL2; Glioma; Inflammation Mediators; Macrophage Inflammatory Proteins; Monokines; Neuroglia; Rats; RNA, Messenger; Taurine; Tumor Cells, Cultured | 1999 |